Scientists test drug safety in people with liver issues
NCT ID NCT07025551
Summary
This study aimed to understand how a drug called MK-8527 is processed by the body in people with mild or moderate liver impairment. Researchers compared the drug's behavior in 18 participants—some with healthy livers and some with liver problems—after they received a single dose. The goal was to gather safety and dosing information for future studies, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arizona Clinical Trials ( Site 0001)
Chandler, Arizona, 85225, United States
Conditions
Explore the condition pages connected to this study.